AEGiS-SC: Urine Test for HIV Virus Seen As 'Near-Term Reality' San Francisco ChronicleImportant note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.
Click here to return to San Francisco Chronicle main menu
DonateNow


Urine Test for HIV Virus Seen As 'Near-Term Reality'

San Francisco Chronicle; Wednesday, August 28, 1991
Lloyd Watson


Calypte Biomedical, the 3-year- old Berkeley firm that will file next month for FDA approval of its urine test for HIV antibodies, has a new chief operating officer: David Robison, the 41-year-old ex- Bristol-Myers exec who led that company's successful development of an FDA-approved HIV blood test.

Calypte founder Howard Urnovitz, 37, continues as president and chief scientific officer.

A Xoma alumnus and former Medical Research Institute senior scientist, Urnovitz predicts that non-invasive urine testing for the HIV virus will be "a reality in the near future . . . I believe these tests will be safer for healthcare workers and expand HIV testing, which is a critical challenge at this stage of the AIDS epidemic."

Last month, Professor Luc Montagnier, 59, of the Institut Pasteur in Paris, joined Calypte's scientific advisory board. The French virologist is the discoverer of the human immunodeficiency virus.

The 15-employee Calypte firm, funded largely by Quest Ventures of Menlo Park and Japan's Otsuka pharmaceutical company, is named for the California hummingbird.


Keywords: AIDS; TESTS; CALYPTE BIOMEDICAL;KWDaids;tests;calyptebiomedical;
910828
SC910811

Copyright © 1991 - San Francisco Chronicle Press. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the San Francisco Chronicle, Permissions Desk, 901 Mission Street, San Franciso, CA 94103. You may also send a fax to (415) 495-3843, or an email message to chronperm@sfgate.com.   http://www.sfgate.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 1991. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1991. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .